ここから本文です

Takeda Pharmaceutical Co. is nearing a preliminary agreement to acquire

Shire Plc after the Japanese drugmaker sweetened its roughly $60 billion bid for the biotechnology company, according to people with knowledge of the matter.

The two companies have been working on a tentative agreement on price and may announce a preliminary accord as early as Tuesday, the people said, declining to be identified as the discussions are confidential. Under U.K. takeover rules, Takeda must announce a firm offer or abandon its pursuit by Wednesday afternoon. The companies may seek an extension from authorities to finalize talks, the people said.

“Takeda’s credit could be downgraded to junk temporarily, probably just for the short-term -- six months or one year’’ if it goes ahead with the acquisition, said Atsushi Seki, an analyst at UBS Securities Japan Co.

今日のBloombergだが、一時的合意に至る可能性に近づいているとあり、最後の3行でもし取得が成立したら、武田の信用は6か月から1年の間はジャンクにまで落ちるとUBSのアナリストがいっているとある。
こんなところを買うのは狂気の沙汰である。